Clinical Trial Update: A Study to Evaluate the Efficacy of Valsartan/Simvastatin Combinations in Patients With Both Essential Hypertension and Hypercholesterolemia [Phase 3]

View source ↗

Summary

Phase 3 study evaluating the efficacy of valsartan/simvastatin combinations in patients with essential hypertension and hypercholesterolemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension
• Hypercholesterolemia

Drugs mentioned

• SIMVASTATIN (SIMVASTATIN)
• VALSARTAN (Valsartan)

Snippet

Sponsor: Novartis | Conditions: Essential Hypertension, Hypercholesterolemia | Phase 3 | Status: COMPLETED